Alabama · 2026 Regular Session · Bill
HB 127: Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 127 is a bill introduced in the Alabama House on January 7, 2026. According to its official title, it concerns: Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine. Primary sponsor: Chip Brown (Republican). Most recent recorded action (January 13, 2026): Read for the first time and referred to the House Committee on Health.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Occupational Licensing Boards
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Chip Brown | Primary sponsor | Republican | House | 105 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Read for the first time and referred to the House Committee on Health
- Pending Committee Action in House of Origin (Health)
- Filed